MacroGenics appoints Margaret Liu, M.D. to Board of Directors effective Jan 3, 2023

MACROGENICS INC

Dr. Liu will serve as a Class II director until the 2024 Annual Meeting or until successor is elected.
She has been appointed to the Science & Technology Committee, effective January 3, 2023.
Initial grant of option to purchase 36,000 shares vesting monthly over 36 months from grant date.
Annual retainer and compensation per the Company's Director Compensation Program as disclosed in April 2022 proxy.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Margaret Liu

Director

MGNX · MACROGENICS INC

Effective: 2023-01-03
Filed: December 21, 2022, 6:59 PM ET

On December 19, 2022, the Board of Directors (the "Board") of MacroGenics, Inc. (the "Company") approved the appointment of Margaret Liu, M.D. to serve as a director on the Board, effective January 3, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Margaret Liu was appointed as Director at MACROGENICS INC.

Action: appointed
Role: Director

Exact text from the filing

On December 19, 2022, the Board of Directors (the "Board") of MacroGenics, Inc. (the "Company") approved the appointment of Margaret Liu, M.D. to serve as a director on the Board, effective January 3, 2023

View on SEC.gov

MACROGENICS INC filing history →

Source: SEC EDGAR

accession 0001125345-22-000113

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.